ArticleCureus2026
Mortality Predictors of Adult Meningeal Tuberculosis: Analysis from a Tertiary Center Using the Lancet Consensus Scoring System.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCompared with other types of central nervous system tuberculosis (TB), meningeal TB has a greater fatality rate. However, data on mortality predictors are limited. This study aimed to determine predictors of mortality in patients with meningeal TBM. STUDY
designThis was a hybrid retrospective-prospective (ambispective) study, in which data were collected retrospectively for patients admitted between January 2019 and December 2020 and prospectively for patients admitted between January 2021 and March 2022. MATERIALS AND
methodsWe conducted an ambispective cohort study of 132 adults (>18 years) with suspected meningitis admitted to the All India Institute of Medical Sciences, Rishikesh, India, between January 2019 and March 2022. Patients were classified as having definite, probable, or possible tuberculous meningitis (TBM) using the Lancet Consensus case definition. The primary outcome was in-hospital mortality. Univariable and multivariable Cox proportional-hazards models were used to identify predictors.
resultsOf the 132 patients enrolled in the study, 66 were classified as having definitive TBM, 12 as probable TBM, 21 as possible TBM, and 33 as non-TBM. The overall mortality rate among patients with any form of TBM (definitive, probable, or possible) was 37.87% (25 deaths), with the highest mortality observed in the definitive TBM group, accounting for 32.3% of deaths (21 cases). Fever, altered sensorium, high serum neutrophil count, low serum lymphocyte count, high CSF lymphocyte count, and low CSF neutrophil count were significantly associated (p<0.05) with the variable definitive TBM as a predictor of mortality in our study.
conclusionsSimple hematological and CSF parameters can help stratify risk in TBM. These markers may guide early clinical decisions and closer monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.